(Bloomberg) -- Subscribe to Prognosis (Spotify) Subscribe to Prognosis (Apple Podcasts)

Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.

©2021 Bloomberg L.P.